FDA Webview Site FDA Review Site FDA Updater Site
header.gif
Username:
Password:
 

human drugs
animal drugs
biologics
eirs 483s
medical devices
marketing
email
search our site
  
FDA-RELATED NEWS
 
 
 
TXT In Era of Government Cuts, FDA Gets $308 Million Boost
05/18/2018
 
 
TXT Azar: I Have a Shocking Amount of Power, Intend to Use It
05/14/2018
 
 
TXT FDA Names Companies Potentially Blocking Generic Samples
05/17/2018
 
 
TXT FDA Sees No Justification for More Device Servicing Regs
05/15/2018
 
 
TXT FDA Backs Away From McClellan Contract: Report
05/17/2018
 
 
TXT Experts Offer Pharmaceutical Reform Plan
05/17/2018
 
 
TXT FDA Alert on Keytruda and Tecentriq Decreased Survival
05/18/2018
 
 
TXT FDA, HHS Guide on IRB Written Procedures
05/17/2018
 
 
TXT FDA Says Inaccuracies in IQVIA Opioid Drug Data
05/16/2018
 
 
TXT Lawyers Say Federal Circuit Strattera Decision Missed Mark
05/17/2018
 
 
TXT Bioresearch Monitoring FY 2017 Metrics Reported
05/16/2018
 
 
TXT U.S. Intervenes in 5 Subsys Whistleblower Suits
05/16/2018
 
 
TXT FDA Approves Hospira’s Epogen Biosimilar
05/15/2018
 
 
TXT HHS Security Alerts Cite Philips, GE, and Silex Devices
05/15/2018
 
 
TXT Latest Federal Register Notices
05/20/2018
 
 
TXT Since Our Last Issue ...
05/20/2018
 
 
TXT Product Approval Summaries
05/20/2018
 
 
TXT Warning on Neural Tube Birth Defects with Tivicay
05/18/2018
 
 
TXT Amgen BLA for Migraine Therapy Approved
05/18/2018
 
 
TXT Draft Guide on Drugs for Cytomegalovirus in Transplantation
05/18/2018
 
 
TXT Medtronic Recalls MindFrame Capture Device
05/18/2018
 
 
TXT Vermont Allows Canadian Drug Imports
05/17/2018
 
 
TXT Complete Response Letter on Evolus Botox Competitor
05/16/2018
 
 
TXT PA Court Upholds Actiq Suit Preemption
05/16/2018
 
 
TXT FDA Updates Med Guides for Gadolinium-based Contrast Agents
05/16/2018
 
 
TXT Steps to Expedite Biosimilar Market Entry: Petition
05/15/2018
 
 
TXT Stakeholders Question Healthcare Professional Survey
05/15/2018
 
 
TXT Latest FDA Warning Letters
05/15/2018
 
 
TXT CGMP Deviations at India’s Reine Lifescience
05/15/2018
 
 
TXT Combo Product Proposed Rule Offers More Transparency
05/14/2018
 
 
 
 
The most authoritative FDA news analysis each week is found in the pages of Dickinson's FDA Review. Since 1984, this newsletter has been providing in-depth reports on the most significant FDA developments affecting the pharmaceutical, medical device, biologics and veterinary medicines industries. Unlike other media, FDA Review eliminates time-wasting minutia and presents in clear, concise language the essence of what's really important - and why. It is the publication that FDA officials themselves read. Delivered in the middle of each week, FDA Review presents:
  • The latest agency policy developments, often before they're officially announced;
  • Major news insights, follow-ups and reactions in each product area;
  • Summaries of the latest Warning Letters;
  • The newest product approvals;
  • Summaries of the latest FDA Federal Register notices;
  • Summaries of DDMAC letters;
  • Related industry news capsules;
  • The industry's most concise FDA news index;
  • Inside-FDA news briefs
You can rely on FDA Review to provide only what's important - in the most convenient and time-saving